On 2025-05-14, Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) announced earnings per share of $-0.20 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.35.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.35 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.35 | $-0.20 |
| 2025-03-24 | 2024-12-31 | $-0.38 | $-0.34 |
| 2024-11-12 | 2024-09-30 | $-0.42 | $-0.37 |
| 2024-08-13 | 2024-06-30 | $-0.38 | $-0.40 |
| 2024-05-13 | 2024-03-31 | $-0.41 | $-0.38 |
| 2024-03-28 | 2023-12-31 | $-0.44 | $-0.38 |
| 2023-11-13 | 2023-09-30 | $-0.46 | $-0.40 |
| 2023-08-14 | 2023-06-30 | $-0.43 | $-0.26 |
| 2023-05-12 | 2023-03-31 | $-0.39 | $-0.53 |
| 2023-03-30 | 2022-12-31 | $-0.48 | $-0.45 |
| 2022-11-10 | 2022-09-30 | $-0.49 | $-0.57 |
| 2022-08-10 | 2022-06-30 | $-0.56 | $-0.69 |
| 2022-05-16 | 2022-03-31 | $-0.69 | $-0.60 |
| 2022-03-30 | 2021-12-31 | $-0.66 | $-0.68 |
| 2021-11-15 | 2021-09-30 | $-0.60 | $-0.45 |
| 2021-08-16 | 2021-06-30 | $-0.59 | $-0.65 |